Compounds > simvastatin
Page last updated: 2024-08-23

simvastatin and Chagas Cardiomyopathy

simvastatin has been researched along with Chagas Cardiomyopathy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castillo, C; Cramer, A; González-Herrera, F; Kemmerling, U; Liempi, A; Machado, FS; Maya, JD; Pimentel, P1
Azevedo, MA; Bahia, MT; Caldas, IS; da Silva do Nascimento, AF; de Figueiredo Diniz, L; de Lima, WG; Figueiredo, VP; Gonçalves, KR; Melo, L; Talvani, A; Torres, RM1
Almeida-Leite, CM; Bahia, MT; Leite, R; Shrestha-Bajracharya, D; Silva, RR; Talvani, A1

Other Studies

3 other study(ies) available for simvastatin and Chagas Cardiomyopathy

ArticleYear
Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    Topics: Animals; Anticholesteremic Agents; Arachidonate 5-Lipoxygenase; Chagas Cardiomyopathy; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; E-Selectin; Endothelium; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Lipoxins; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocardium; Nitroimidazoles; Parasitemia; Simvastatin; Survival Analysis; Trypanocidal Agents; Trypanosoma cruzi; Vascular Cell Adhesion Molecule-1

2017
Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.
    The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:2

    Topics: Animals; Chagas Cardiomyopathy; Dog Diseases; Dogs; Female; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Interleukin-10; Male; Myocardium; Polymerase Chain Reaction; Simvastatin; Stroke Volume; Trypanosoma cruzi; Tumor Necrosis Factor-alpha

2011
Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.
    Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:4

    Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Disease Models, Animal; Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interferon-gamma; Male; Mice; Mice, Inbred C57BL; Myocarditis; Simvastatin; Time Factors; Tumor Necrosis Factor-alpha

2012